PATENT CLAIM ANALYSIS

Application Number: 16136065
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "108000"]

Abstract:
Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions, such as arthritis.

Claim (Index 15):
The method of  claim 11 , wherein the dosage form contains about 0.5 mg to about 10 mg of the zoledronic acid.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 97.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15604394', '15697267', '15403073', '15439774', '15702616']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8227392283580724
- 35 USC 102 Novelty (BERT): 0.612677475486107
- Combined Prediction Score: 0.801733053070876
- Mean Citation Score: 609.103108
- Max Citation Score: 615.6008
- Similarity Product: 460.2904274215698

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test